EMBioSys has developed Efinia™, a new treatment modality to improve cancer outcomes. Efinia™ delivers iEF Therapy (low intensity induced electric fields) to the treat the patient from the comfort of home, or while on the go. iEF Therapy has the potential to inhibit cancer metastasis, shrink the primary tumor, improve efficacy of standard of care chemotherapy, and boost the natural immune response while selectively targeting only cancer cells. This novel platform technology offers physicians a low risk, easily tolerated therapy to potentiate the standard of care for treatment of solid tumors, starting with breast cancer.
| Website | https://www.embiosys.com/ |
| Employees | 4 (2 on RocketReach) |
| Founded | 2022 |
| Phone | +1 978-771-4662 |
| Industry | Medical Equipment Manufacturing |
| Keywords | Wearable Technology, Cancer Treatment, Solid Tumor Treatment, Cancer Therapies, Oncology Technology, Medical Devices, Medical Wearable, Platform Technology, Healthcare Technology, Biomedical Engineering |
Looking for a particular EMBioSys employee's phone or email?
EMBioSys Questions
Chris Barron is the Co-Founder and CEO of EMBioSys.
2 people are employed at EMBioSys.
Top EMBioSys Employees
-
Chris Barron
Co-Founder and CEO at EMBioSys
Boston, MA, US23 -
Vish Subramaniam
Co-Founder, President, and CSO at EMBioSys
Toronto, ON, CA32
